Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06509373 · ClinicalTrials.gov registry record · NA
A Portal-based Advance Care Planning Intervention Among Community-Dwelling Persons Living With Cognitive Impairment
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 300
- Enrollment target
NCT06509373: Completed NA study, sponsored by Wake Forest University Health Sciences.
NCT06509373 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 300 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06509373, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
Study Summary
The purpose of this research is to examine the feasibility of using a patient portal based advance care planning (ACP) tool to improve ACP discussions and documentation in persons living with cognitive impairment in outpatient primary care.
Primary Outcome
Percentage of participants who open the advance care planning tool (ACPVoice) mychart message
Interventions
- BEHAVIORAL Advance Care Planning Tool - ACPVoice
- BEHAVIORAL Standard of Care for Advance Care Planning
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2024-08-19 |
| Est. Completion | 2025-06-27 |
| Phase | NA |
What the finished NCT06509373 record still lists
NCT06509373 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).
The record links to 0 conditions, and to 2 interventions - of which Advance Care Planning Tool - ACPVoice is the first listed.
NCT06509373 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06509373 about?
NCT06509373 is a clinical study titled "A Portal-based Advance Care Planning Intervention Among Community-Dwelling Persons Living With Cognitive Impairment". The purpose of this research is to examine the feasibility of using a patient portal based advance care planning (ACP) tool to improve ACP discussions and documentation in persons living with cognitive impairment in outpatient primary care.
What is the current status of trial NCT06509373?
This trial is currently completed. It is a NA study. The enrollment target is 300 participants. The study started on 2024-08-19. Estimated completion is 2025-06-27.
What interventions are being tested in trial NCT06509373?
The interventions under investigation include: Advance Care Planning Tool - ACPVoice (BEHAVIORAL), Standard of Care for Advance Care Planning (BEHAVIORAL).
Who is sponsoring clinical trial NCT06509373?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06509373's enrollment target sits among peer trials
300 330th of 2000 higher than 1,630 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI